Baloxavir powder CAS 1985605-59-1, a third-generation antiviral chemical, is the first novel anti-influenza drug approved by THE US FDA in the past 20 years.

Product Name: CAS 1985605-59-1 Baloxavir powder

Synonyms: Baloxavir;CPD2051;Baloxavir Impurity 10;S-033447

CAS: 1985605-59-1

Assay： 99%

MF： C24-H19-F2-N3-O4-S

MW： 483.4931

Standard： Pharmacopoeia

Appearance： White or off-white crystalline powder

Package： In aluminium foil bag or 25kg/ drum

Product Application :

CAS 1985605-59-1 Baloxavir powder has a novel anti-influenza mechanism aimed at combating both influenza A and Influenza B viruses, including tamiflu (Oseltamivir) resistant strains and avian influenza strains (H7N9, H5N1).

Contact information: 

http://www.yutbonpharma.com/